GSEA revealed that the expression of FBXO16 is negatively correlated with various cancer-promoting signaling pathways, suggesting that FBXO16 may regulate these signaling pathways in ovarian cancer. The gene discussed is FBXO16; the disease is ovarian carcinoma.